Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Enlivex Ltd., a Nasdaq-listed company, announced a significant surge in trading volume on its Rain protocol, reaching $860 million in July 2026, representing a 622% month-over-month increase from June. The company expects the Rain protocol's trading volumes to grow exponentially in the coming years, forecasted to reach $33 billion by 2029, driving …
Diginex Limited announced it has regained compliance with Nasdaq's minimum bid price requirement after its stock price stayed at or above $1.00 for 20 consecutive business days, thus preserving its Nasdaq listing status. This marks recovery from a previous warning received in March 2026 due to its share price falling below the required threshold. D…
Intel's Q2 results show the core Data Center & AI business firing on all cylinders while the foundry investment phase creates headline noise. With revenue up 25% and DCAI up 59%, current weakness offers an actionable long trade at $85.24 with defined risk and a $110 target over a 180-trading-day horizon.
Innventure, Inc., an industrial growth conglomerate listed on NASDAQ under the ticker INV, announced it will release its Q2 2026 financial results on August 13, 2026. The release will be followed by a conference call including remarks from the incoming CEO Dr. Bill Grieco and CEO of Accelsius, John Hewitt. The company focuses on building scalable i…
Aligos Therapeutics, a clinical-stage biopharmaceutical company specializing in therapies for liver and viral diseases, announced it will release its Q2 2026 financial results on August 6, 2026, prior to U.S. market open. The company focuses on developing treatments for conditions like chronic hepatitis B virus infection.
Gentherm, a leader in thermal management and pneumatic comfort technologies, announced its participation in two upcoming investor conferences, including a fireside chat at the J.P. Morgan Auto Conference and hosting investors at the Seaport Annual Summer Investor Conference. The events aim to provide insights into the company's performance and outl…
Aureus Greenway Holdings Inc. (Nasdaq: PUSA) has filed a Form S-4 registration statement with the SEC as part of its proposed business combination with Autonomous Power Corporation (dba Powerus). The merger aims to position the combined entity as a leader in domestically produced defense autonomy and counter-drone technology. The combined company w…
Nuwellis, Inc. announced acceptance of a retrospective study in Frontiers in Pediatrics demonstrating that epoprostenol is a safe and feasible alternative anticoagulant for Aquadex ultrafiltration therapy in critically ill pediatric patients. This supports broader adoption of Aquadex therapy and offers clinicians an additional tool for complicated …
Avery Dennison Corp. stock climbed sharply in pre-market trading after the company reported second-quarter results that exceeded analyst estimates and provided full-year 2026 EPS guidance that sits at or above consensus. The move came despite a cautious analyst setup heading into the report and was supported by a positive broader market backdrop.
UBS has revised up its 2026 forecasts for China’s trade, pointing to AI-related commerce as a dominant factor in stronger-than-expected performance in the first half of 2026. Exports rose 18% year-over-year and imports 26% in H1, with AI-linked trade accounting for nearly half of growth. UBS now expects 2026 nominal export growth of about 18% and i…
Baxter International rallied sharply in pre-market trading after delivering second-quarter 2026 results that outpaced analyst forecasts on both earnings and revenue, and after lifting its full-year adjusted EPS guidance. The company also shifted to a two-segment reporting model aimed at clearer visibility into core operations. The combination of th…
Vericel Corporation announced robust second quarter 2026 financial results with a 22% revenue increase to $77.5 million led by strong growth in MACI and Burn Care products. The company raised its full-year revenue guidance to $330-$340 million and authorized a $200 million share repurchase program, reflecting confidence in continued growth. Positiv…
Tenable shares plunged 15.0% in pre-market trading after the cybersecurity firm posted better-than-expected adjusted EPS and revenue for Q2 2026, but issued third-quarter revenue guidance below Street expectations and reported decelerating subscription growth. A notable analyst downgrade intensified the selloff, even as major U.S. indices moved hig…
Sonic Automotive fell 2.3% in pre-market trading after reporting Q2 2026 EPS of $1.82 on revenue of $3.9 billion, both edging past analyst expectations. The stock opened as low as $103.70 before recovering to $110.01, a move driven more by stretched valuations and profit-taking than by the quarterly numbers themselves. Market volatility tied to rec…
Microsoft reported strong Q4 results and an Azure growth rate that validates the Copilot strategy. Valuation is reasonable for a $2.9T behemoth with $73B in free cash flow, and technical momentum supports an entry near current levels. I'm upgrading to Buy with a medium risk rating, but investors should monitor ongoing capex and margin mix as the AI…
Porch Group shares jumped sharply in pre-market trading after the company posted second-quarter results that outperformed analyst expectations on revenue and earnings, raised 2026 guidance across key metrics, and disclosed a large stake held by BlackRock. Strong growth in the Insurance Services segment and a sizable rise in adjusted EBITDA helped f…
Altria Group reported second-quarter adjusted earnings per share of $1.48, narrowly below the LSEG consensus of $1.50, as weakness in premium cigarette and nicotine pouch demand weighed on results. Revenue net of excise taxes rose modestly to $5.36 billion, slightly ahead of expectations. The company pointed to higher fuel and everyday living costs…
Stantec, partnered with Johnson, Mirmiran and Thompson, secured a $150 million joint venture contract from the U.S. Army Corps of Engineers to design more than eight miles of integrated coastal storm risk management infrastructure on Charleston's peninsula. The project includes storm surge barriers, floodwalls, levees, pump stations, and nature-bas…
Las Vegas Sands Corp. shares fell in pre-market trading after Argus Research downgraded the stock from Buy to Hold. The downgrade compounds investor caution that has been building since LVS reported weaker-than-expected Q2 2026 results, with management pointing to unusually low hold rates in Macao as the primary driver of the shortfall.
Crescent Biopharma reported strong second-quarter 2026 results highlighting progress in multiple clinical trials for its novel cancer therapies, including CR-001, CR-002, and CR-003. The company completed a $143.7 million public offering, extending its cash runway into mid-2028, supporting ongoing development and upcoming clinical data readouts in …
Align Technology stock fell sharply in pre-market trading after the company issued third-quarter 2026 revenue guidance below analyst expectations alongside quarterly results. While quarterly revenue and adjusted earnings per share were broadly in line and clear aligner volume hit a record, weakness in Systems and Services, a £37.5 million (reported…
Block, Inc. director Anthony Mathew Eisen completed a series of share transactions that realized approximately $1.42 million in proceeds. The sales align with a broader wave of institutional upgrades, elevated equity valuations, and strategic product deployments designed to enhance merchant engagement and consumer retention.
ImmunityBio (NASDAQ:IBRX) saw its stock climb 7.5% on Thursday after the Emirates Drug Establishment granted marketing authorizations for ANKTIVA across two indications: BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) in combination with BCG, and metastatic non-small cell lung cancer (NSCLC) in combination with immune checkpoint inhibit…
The European Commission has unveiled plans to finance seven AI gigafactories across the European Union with a budget of €10 billion, up from an initial five, and aims to attract at least €20 billion in private investment. The facilities will integrate advanced AI processors, software, cloud infrastructure, high-speed connectivity and data centres, …
ACES (ALPS Clean Energy ETF) tracks U.S. and Canada-listed clean-energy names. Trading at $29.56 and sitting near its 52-week low, ACES shows an oversold technical profile (RSI ~28) while the clean-energy thematic continues to attract capital. This trade idea proposes a long position with entry at $29.50, stop at $27.00, and a $36.00 target over a …
